hotspot -WSS

hotspot

author：hotspot 2025-09-30 01:19:38 - browse：45711

Chemotherapy infusion — The White House outlined its efforts to end shortages of three key generic chemotherapies. But experts want more more details. Gerry Broome/AP

WASHINGTON — The White House says it’s working to end shortages of three key generic chemotherapies. But experts said the administration would have to provide more details to fully mitigate the health care system’s concerns.

Carboplatin, cisplatin, and methotrexate are three of 15 cancer drugs in shortage in the United States. They have been staples of cancer treatment for decades, according to a White House blog post, but their supply in the United States has been nearly halved in the past year. The shortages have forced doctors to ration the drugs and alter treatment plans, leaving cancer patients to wonder whether their survival odds are hurt.

In its blog post, the White House noted that it’s now allowing Chinese imports of cisplatin. The Food and Drug Administration is also working with generic drug companies to boost production of all three drugs, but it didn’t say which companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Rune Labs, whose app tracks Parkinson's symptoms, raises $12M

WSS

Allen Institute goes after foundational questions, CEO Costa says

At JPM 2024, hospital systems pitch financial strength to investors

Life science postdocs should get big pay hike, NIH panel says

Study suggests new cause of Down syndrome: cells linked to aging

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Mega Millions pot grows to $1.25 billion after no winner

Wikipedia

hotspot

Wikipedia

At least 13 dead in Texas as scorching temps continue

Nonprofit, backed by Microsoft, to certify AI tools in health care

Continuity nursing helped my family in our darkest PICU moments

What the US credit downgrade means for the economy, your finances

Medicare details structure of new drug price negotiation program

FDA early review: GLP

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

A preacher's new calling: Diversifying neuroscience research

Drug repurposing or repositioning? The language matters

Fauci's latest grilling in Congress: 9 hours, behind closed doors

explore

‘Oppenheimer’ and the risks of AI in health care

At JPM 2024, hospital systems pitch financial strength to investors

Breakthrough Alzheimer’s drugs are inaccessible in rural states

Physician assistants need a new name. Here's what it should be

Ascension's ugly legal battle over care for poor patients in Texas

Mitch McConnell episode has important public health takeaway

explore

knowledge

knowledge

focus